Yale Cancer Center (YCC) scientists presented research at the 62nd annual American Society for Radiation Oncology (ASTRO) virtual meeting held October 25-28. The conference brings together clinicians and researchers from all oncology disciplines to exchange ideas and promote multidisciplinary care for cancer. Research and session highlights from YCC scientists include:
A Multi-Institutional External Validation of a Deep-Learning Based Platform for Prediction of Outcomes following SBRT Treatment for Early-Stage Non-Small Cell Lung Cancer
Abstract: 1103
Author: Sanjay Aneja
Post-Operative Radiation Therapy for Non-Small Cell Lung Cancer: A Comparison of Radiation Therapy Techniques
Abstract: 2288
Authors: Vikram Jairam, Roy H. Decker
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma with Brain Metastases
Abstract: 3709
Authors: Veronica L. Chiang
Nanoparticle-Encapsulated NAMPT Inhibitors Administered via Convection Enhanced Delivery as a Novel Glioma Radiosensitization Strategy
Abstract: 3316
Authors: Jason M. Beckta, Ranjit S. Bindra
Overcoming Barriers to Radiation Oncology Access in Low-Resource Environments
Moderator: Henry Soo-Min Park, MD, MPH
The Applicability of Hypofractionation for Breast, Prostate and Head and Neck Cancers: A Case-Based, Resource-Stratified Panel Discussion
Presenter: Meena S. Moran, MD
For more information about YCC participation at ASTRO 2020: YCC ASTRO 2020